TCG Crossover Fund II, L.P.

Sociétés où TCG Crossover Fund II, L.P. a négocié

• Surrozen, Inc./DE14 tx · $4.7M · Mar 25, 2026

Historique de performance de TCG Crossover Fund II, L.P.

Historique des transactions de TCG Crossover Fund II, L.P.

Co-initiés de TCG Crossover Fund II, L.P.

• TCG Crossover Fund III, L.P.Surrozen, Inc./DE +1
• TCG Crossover GP III, LLCSurrozen, Inc./DE +1
• TCG Crossover GP II, LLCSurrozen, Inc./DE +1
• 5AM Opportunities I (GP), LLCVor Biopharma Inc.
• 5AM Opportunities I, L.P.Vor Biopharma Inc.
• 5AM Partners VI, LLCVor Biopharma Inc.
• 5AM Ventures VI, L.P.Vor Biopharma Inc.
• Alexandria Venture Investments, LLCVor Biopharma Inc.
• ANG ROBERTVor Biopharma Inc.
• Attar Eyal C.Vor Biopharma Inc.
• Beckman DaniellaVor Biopharma Inc.
• Berkenblit AnnaSurrozen, Inc./DE
• BJERKHOLT ERICSurrozen, Inc./DE
• BLUTT MITCHELL J MDSurrozen, Inc./DE
• CHAI CHRISTOPHER YSurrozen, Inc./DE
• Chakraborty TirthaVor Biopharma Inc.
• Choi Han WookVor Biopharma Inc.
• COLUMN GROUP III-A, LPSurrozen, Inc./DE
• COLUMN GROUP III GP, LPSurrozen, Inc./DE
• COLUMN GROUP III, LPSurrozen, Inc./DE
• Column Group Opportunity III GP, LPSurrozen, Inc./DE
• Column Group Opportunity III, LPSurrozen, Inc./DE
• Consonance Capital Management LPSurrozen, Inc./DE
• Consonance Capital Opportunity Fund Management LPSurrozen, Inc./DE
• Consonance Capman GP, LLCSurrozen, Inc./DE
• Consonance Life SciencesSurrozen, Inc./DE
• Cumbo AlexanderVor Biopharma Inc.
• Detheux MichelVor Biopharma Inc.
• Haak-Frendscho MarySurrozen, Inc./DE
• Haqq ChristopherSurrozen, Inc./DE
• Hoffman ReidVor Biopharma Inc.
• House Joshua CorySurrozen, Inc./DE